The tumors in NCM460-STK33-injected mice first appeared at 17 days, and the final average tumor weights and tumor growth curves showed that STK33 overexpression promotes NCM460 cells tumorigenic in vivo (Figure 2F). The gene discussed is STK33; the disease is neoplasm.